Uniform onko does not work

Uniform onko does not work Preparations for a cancer therapy lower on regional level not entering the list of the vital medicines (ZhNVLP) of medicine from a cancer "Abraksan" from the American BMS and "Pikrey" from the Swiss Novartis Int AG, included in 2023 in financed at the expense of obligatory medical insurance (compulsory health insurance) of the scheme of treatment, from next year will be excluded from this mechanism. Now regions at own expense should get preparations, government purchases which in January — September of the current year grew almost by 63% year by a year. It will result in difficulties in receiving by patients...